Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Fly Intel: After-Hours Movers » 18:33
12/08/21
12/08
18:33
12/08/21
18:33
RH

RH

$577.59 /

+1.2 (+0.21%)

, GEF

Greif

$63.09 /

+0.23 (+0.37%)

, LIDR

AEye

$5.22 /

+0.355 (+7.30%)

, CURV

Torrid

$15.69 /

-0.85 (-5.14%)

, RENT

Rent The Runway

$11.46 /

-1.3 (-10.19%)

, PHR

Phreesia

$53.96 /

+0.635 (+1.19%)

, GME

GameStop

$173.47 /

-4.21 (-2.37%)

, PATH

UiPath

$47.70 /

+0.8 (+1.71%)

, LCID

Lucid Group

$44.70 /

+0.84 (+1.92%)

, FUBO

FuboTV

$19.77 /

+1.175 (+6.32%)

, PERI

Perion Network

$24.46 /

+0.16 (+0.66%)

Check out this evening's…

ShowHide Related Items >><<
RH RH
$577.59 /

+1.2 (+0.21%)

PHR Phreesia
$53.96 /

+0.635 (+1.19%)

PERI Perion Network
$24.46 /

+0.16 (+0.66%)

PATH UiPath
$47.70 /

+0.8 (+1.71%)

LIDR AEye
$5.22 /

+0.355 (+7.30%)

LCID Lucid Group
$44.70 /

+0.84 (+1.92%)

GME GameStop
$173.47 /

-4.21 (-2.37%)

GEF Greif
$63.09 /

+0.23 (+0.37%)

FUBO FuboTV
$19.77 /

+1.175 (+6.32%)

CURV Torrid
$15.69 /

-0.85 (-5.14%)

RH RH
$577.59 /

+1.2 (+0.21%)

12/06/21 Wedbush
RH price target lowered to $600 from $760 at Wedbush
11/29/21 BofA
Arhaus initiated with a Buy at BofA
09/09/21 Loop Capital
RH continued to impress with Q2 results, says Loop Capital
09/09/21 Wedbush
RH price target raised to $760 from $720 at Wedbush
GEF Greif
$63.09 /

+0.23 (+0.37%)

11/29/21 Wells Fargo
Wells Fargo cuts Greif to Equal Weight, lowers price target to $75
11/29/21 Wells Fargo
Greif downgraded to Equal Weight from Overweight at Wells Fargo
11/11/21 BMO Capital
Greif downgraded to Market Perform from Outperform at BMO Capital
10/14/21 BofA
Greif downgraded to Neutral from Buy at BofA
LIDR AEye
$5.22 /

+0.355 (+7.30%)

11/10/21 DA Davidson
AEye initiated with Buy, $15 target at DA Davidson
11/10/21 DA Davidson
AEye initiated with a Buy at DA Davidson
10/25/21 Roth Capital
AEye initiated with a Buy at Roth Capital
09/23/21 Guggenheim
AEye initiated with a Buy at Guggenheim
CURV Torrid
$15.69 /

-0.85 (-5.14%)

11/30/21 Jefferies
Torrid assumed with a Buy at Jefferies
07/26/21 Cowen
Cowen starts 'best-in-class' Torrid at Outperform with $30 target
07/26/21 Morgan Stanley
Torrid initiated with an Overweight at Morgan Stanley
07/26/21 Jefferies
Torrid initiated with a Buy at Jefferies
RENT Rent The Runway
$11.46 /

-1.3 (-10.19%)

11/22/21
Fly Intel: Top five analyst initiations
11/22/21 Morgan Stanley
Morgan Stanley starts 'underestimated' Rent The Runway with an Overweight
11/22/21 KeyBanc
KeyBanc bullish on Rent The Runway, initiates with an Overweight
11/22/21 Wells Fargo
Wells Fargo bullish on Rent The Runway, initiates with an Overweight
PHR Phreesia
$53.96 /

+0.635 (+1.19%)

12/01/21 Jefferies
Phreesia initiated with a Buy at Jefferies
09/03/21 SVB Leerink
SVB Leerink says buy the dip in Phreesia
09/03/21 Raymond James
Phreesia price target raised to $75 from $65 at Raymond James
09/03/21 Piper Sandler
Phreesia earnings selloff a buying opportunity, says Piper Sandler
GME GameStop
$173.47 /

-4.21 (-2.37%)

09/27/21 Ascendiant
Ascendiant keeps Sell rating on GameStop, cuts price target to $24
07/12/21 Ascendiant
GameStop price target raised to $25 from $10 at Ascendiant
06/28/21 Baird
Baird suspends GameStop rating pending business strategy clarity
06/10/21 Wedbush
GameStop price target raised to $50 from $39 at Wedbush
PATH UiPath
$47.70 /

+0.8 (+1.71%)

12/03/21 Morgan Stanley
Morgan Stanley raises UiPath to Overweight following 42% post-IPO pullback
12/03/21 Morgan Stanley
UiPath upgraded to Overweight from Equal Weight at Morgan Stanley
12/01/21 BMO Capital
UiPath price target lowered to $57 from $70 at BMO Capital
11/29/21 Cleveland Research
UiPath initiated with a Neutral at Cleveland Research
LCID Lucid Group
$44.70 /

+0.84 (+1.92%)

11/17/21 Morgan Stanley
Lucid Group price target raised to $16 from $12 at Morgan Stanley
11/16/21 Citi
Lucid Group price target raised to $57 from $28 at Citi
11/10/21 BofA
Lucid Group price target raised to $60 from $30 at BofA
11/10/21 BofA
Tesla price target raised to $1,200 from $1,000 at BofA
FUBO FuboTV
$19.77 /

+1.175 (+6.32%)

11/15/21 Barrington
FuboTV downgraded to Market Perform from Outperform at Barrington
11/15/21 Barrington
FuboTV downgraded to Market Perform from Outperform at Barrington
10/26/21 BTIG
FuboTV initiated with a Neutral at BTIG
10/26/21 BTIG
FuboTV initiated with a Neutral at BTIG
PERI Perion Network
$24.46 /

+0.16 (+0.66%)

10/26/21 Roth Capital
Perion Network price target raised to $43 from $40 at Roth Capital
10/26/21 Oppenheimer
Oppenheimer ups Perion target to $35, sees 'favorable backdrop' in Q4
10/26/21 Oppenheimer
Perion Network price target raised to $35 from $30 at Oppenheimer
10/06/21 Roth Capital
Perion Network price target raised to $40 from $35 at Roth Capital
RH RH
$577.59 /

+1.2 (+0.21%)

RENT Rent The Runway
$11.46 /

-1.3 (-10.19%)

PHR Phreesia
$53.96 /

+0.635 (+1.19%)

PERI Perion Network
$24.46 /

+0.16 (+0.66%)

PATH UiPath
$47.70 /

+0.8 (+1.71%)

LIDR AEye
$5.22 /

+0.355 (+7.30%)

LCID Lucid Group
$44.70 /

+0.84 (+1.92%)

GME GameStop
$173.47 /

-4.21 (-2.37%)

GEF Greif
$63.09 /

+0.23 (+0.37%)

FUBO FuboTV
$19.77 /

+1.175 (+6.32%)

CURV Torrid
$15.69 /

-0.85 (-5.14%)

  • 09
    Dec
  • 27
    Oct
  • 29
    Jun
  • 01
    Jul
  • 18
    Jun
  • 21
    Apr
  • 08
    Apr
  • 20
    Jan
  • 30
    Dec
RH RH
$577.59 /

+1.2 (+0.21%)

LCID Lucid Group
$44.70 /

+0.84 (+1.92%)

GME GameStop
$173.47 /

-4.21 (-2.37%)

FUBO FuboTV
$19.77 /

+1.175 (+6.32%)

RH RH
$577.59 /

+1.2 (+0.21%)

RENT Rent The Runway
$11.46 /

-1.3 (-10.19%)

PERI Perion Network
$24.46 /

+0.16 (+0.66%)

PATH UiPath
$47.70 /

+0.8 (+1.71%)

LIDR AEye
$5.22 /

+0.355 (+7.30%)

LCID Lucid Group
$44.70 /

+0.84 (+1.92%)

GME GameStop
$173.47 /

-4.21 (-2.37%)

GEF Greif
$63.09 /

+0.23 (+0.37%)

FUBO FuboTV
$19.77 /

+1.175 (+6.32%)

CURV Torrid
$15.69 /

-0.85 (-5.14%)

RH RH
$577.59 /

+1.2 (+0.21%)

RENT Rent The Runway
$11.46 /

-1.3 (-10.19%)

PHR Phreesia
$53.96 /

+0.635 (+1.19%)

PERI Perion Network
$24.46 /

+0.16 (+0.66%)

PATH UiPath
$47.70 /

+0.8 (+1.71%)

LIDR AEye
$5.22 /

+0.355 (+7.30%)

LCID Lucid Group
$44.70 /

+0.84 (+1.92%)

GME GameStop
$173.47 /

-4.21 (-2.37%)

GEF Greif
$63.09 /

+0.23 (+0.37%)

FUBO FuboTV
$19.77 /

+1.175 (+6.32%)

CURV Torrid
$15.69 /

-0.85 (-5.14%)

Earnings
Phreesia sees FY23 revenue up 20%-25% » 16:09
12/08/21
12/08
16:09
12/08/21
16:09
PHR

Phreesia

$54.01 /

+0.69 (+1.29%)

The company states:…

The company states: "We expect revenue for Fiscal Year 2023 to grow in the range of 20 to 25% above Fiscal Year 2022 revenue. We also anticipate a continued acceleration in investments in Fiscal Year 2023 from Fiscal Year 2022 levels and will provide an outlook for Adjusted EBITDA for Fiscal Year 2023 when we release our full Fiscal Year 2022 results in March 2022."

ShowHide Related Items >><<
PHR Phreesia
$54.01 /

+0.69 (+1.29%)

PHR Phreesia
$54.01 /

+0.69 (+1.29%)

12/01/21 Jefferies
Phreesia initiated with a Buy at Jefferies
09/03/21 SVB Leerink
SVB Leerink says buy the dip in Phreesia
09/03/21 Raymond James
Phreesia price target raised to $75 from $65 at Raymond James
09/03/21 Piper Sandler
Phreesia earnings selloff a buying opportunity, says Piper Sandler
PHR Phreesia
$54.01 /

+0.69 (+1.29%)

  • 08
    Apr
PHR Phreesia
$54.01 /

+0.69 (+1.29%)

PHR Phreesia
$54.01 /

+0.69 (+1.29%)

Earnings
Phreesia raises FY22 revenue view to $211M from $195M-$198M  16:07
12/08/21
12/08
16:07
12/08/21
16:07
PHR

Phreesia

$54.09 /

+0.77 (+1.44%)

Consensus $198.3M

ShowHide Related Items >><<
PHR Phreesia
$54.09 /

+0.77 (+1.44%)

PHR Phreesia
$54.09 /

+0.77 (+1.44%)

12/01/21 Jefferies
Phreesia initiated with a Buy at Jefferies
09/03/21 SVB Leerink
SVB Leerink says buy the dip in Phreesia
09/03/21 Raymond James
Phreesia price target raised to $75 from $65 at Raymond James
09/03/21 Piper Sandler
Phreesia earnings selloff a buying opportunity, says Piper Sandler
PHR Phreesia
$54.09 /

+0.77 (+1.44%)

  • 08
    Apr
PHR Phreesia
$54.09 /

+0.77 (+1.44%)

PHR Phreesia
$54.09 /

+0.77 (+1.44%)

Earnings
Phreesia reports Q3 EPS (71c), consensus (38c) » 16:06
12/08/21
12/08
16:06
12/08/21
16:06
PHR

Phreesia

$54.30 /

+0.98 (+1.84%)

Reports Q3 revenue…

Reports Q3 revenue $55.9M, consensus $48.75M. "We celebrated an important milestone in September as we surpassed 100 million patient visits enabled by our platform during the previous twelve months", said CEO and Co-Founder Chaim Indig. "Every member of the Phreesia team has contributed to this achievement; I would like to congratulate them on reaching this milestone, and thank our clients for entrusting us to create a better, more engaging healthcare experience".

ShowHide Related Items >><<
PHR Phreesia
$54.30 /

+0.98 (+1.84%)

PHR Phreesia
$54.30 /

+0.98 (+1.84%)

12/01/21 Jefferies
Phreesia initiated with a Buy at Jefferies
09/03/21 SVB Leerink
SVB Leerink says buy the dip in Phreesia
09/03/21 Raymond James
Phreesia price target raised to $75 from $65 at Raymond James
09/03/21 Piper Sandler
Phreesia earnings selloff a buying opportunity, says Piper Sandler
PHR Phreesia
$54.30 /

+0.98 (+1.84%)

  • 08
    Apr
PHR Phreesia
$54.30 /

+0.98 (+1.84%)

PHR Phreesia
$54.30 /

+0.98 (+1.84%)

Options
Phreesia options imply 16.2% move in share price post-earnings » 14:34
12/08/21
12/08
14:34
12/08/21
14:34
PHR

Phreesia

$54.51 /

+1.19 (+2.23%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PHR Phreesia
$54.51 /

+1.19 (+2.23%)

PHR Phreesia
$54.51 /

+1.19 (+2.23%)

12/01/21 Jefferies
Phreesia initiated with a Buy at Jefferies
09/03/21 SVB Leerink
SVB Leerink says buy the dip in Phreesia
09/03/21 Raymond James
Phreesia price target raised to $75 from $65 at Raymond James
09/03/21 Piper Sandler
Phreesia earnings selloff a buying opportunity, says Piper Sandler
PHR Phreesia
$54.51 /

+1.19 (+2.23%)

  • 08
    Apr
PHR Phreesia
$54.51 /

+1.19 (+2.23%)

Over a week ago
Initiation
Phreesia initiated with a Buy at Jefferies » 16:16
12/01/21
12/01
16:16
12/01/21
16:16
PHR

Phreesia

$54.24 /

-3.625 (-6.26%)

Jefferies analyst Glen…

Jefferies analyst Glen Santangelo initiated coverage of Phreesia with a Buy rating and $70 price target. Given the company's position as a provider of patient intake services, improved utilization could present upside to 2022 and 2023 revenue estimates, Santangelo tells investors in a research note. The analyst agrees with Phreesia's strategy of reinvesting in sales and infrastructure to drive future growth.

ShowHide Related Items >><<
PHR Phreesia
$54.24 /

-3.625 (-6.26%)

PHR Phreesia
$54.24 /

-3.625 (-6.26%)

09/03/21 SVB Leerink
SVB Leerink says buy the dip in Phreesia
09/03/21 Raymond James
Phreesia price target raised to $75 from $65 at Raymond James
09/03/21 Piper Sandler
Phreesia earnings selloff a buying opportunity, says Piper Sandler
09/03/21 Baird
Phreesia price target raised to $67 from $62 at Baird
PHR Phreesia
$54.24 /

-3.625 (-6.26%)

  • 08
    Apr
PHR Phreesia
$54.24 /

-3.625 (-6.26%)

Over a month ago
Conference/Events
Phreesia management to meet virtually with JMP Securities » 04:55
09/28/21
09/28
04:55
09/28/21
04:55
PHR

Phreesia

$64.55 /

-0.75 (-1.15%)

Virtual Meeting to be…

Virtual Meeting to be held on September 28 hosted by JMP Securities.

ShowHide Related Items >><<
PHR Phreesia
$64.55 /

-0.75 (-1.15%)

PHR Phreesia
$64.55 /

-0.75 (-1.15%)

09/03/21 SVB Leerink
SVB Leerink says buy the dip in Phreesia
09/03/21 Raymond James
Phreesia price target raised to $75 from $65 at Raymond James
09/03/21 Piper Sandler
Phreesia earnings selloff a buying opportunity, says Piper Sandler
09/03/21 Baird
Phreesia price target raised to $67 from $62 at Baird
PHR Phreesia
$64.55 /

-0.75 (-1.15%)

  • 08
    Apr
  • 21
    Oct
PHR Phreesia
$64.55 /

-0.75 (-1.15%)

Conference/Events
Phreesia management to meet virtually with JMP Securities » 13:26
09/21/21
09/21
13:26
09/21/21
13:26
PHR

Phreesia

$66.82 /

+3.42 (+5.39%)

Virtual Meeting to be…

Virtual Meeting to be held on September 28 hosted by JMP Securities.

ShowHide Related Items >><<
PHR Phreesia
$66.82 /

+3.42 (+5.39%)

PHR Phreesia
$66.82 /

+3.42 (+5.39%)

09/03/21 SVB Leerink
SVB Leerink says buy the dip in Phreesia
09/03/21 Raymond James
Phreesia price target raised to $75 from $65 at Raymond James
09/03/21 Piper Sandler
Phreesia earnings selloff a buying opportunity, says Piper Sandler
09/03/21 Baird
Phreesia price target raised to $67 from $62 at Baird
PHR Phreesia
$66.82 /

+3.42 (+5.39%)

  • 08
    Apr
  • 21
    Oct
PHR Phreesia
$66.82 /

+3.42 (+5.39%)

Over a quarter ago
Hot Stocks
Phreesia gets HITRUST CSF certification for enhanced security and compliance » 08:28
09/08/21
09/08
08:28
09/08/21
08:28
PHR

Phreesia

$69.61 /

+2.485 (+3.70%)

Phreesia announces that…

Phreesia announces that its patient intake platform has earned renewed HITRUST CSF Certification for information security. The designation validates Phreesia's commitment to meeting key regulations and protecting sensitive information. "This recertification underscores Phreesia's dedication to safeguarding sensitive personal health and financial information," said Wes Shriner, Phreesia's Senior Director of Information Security. "We prioritize security in every decision we make as an organization. This continuous third-party examination gives patients and providers using our platform confidence that their information is safe with Phreesia." HITRUST CSF Certified status demonstrates that Phreesia's patient intake platform has met key regulations and industry-defined requirements and is appropriately managing risk. This achievement places Phreesia in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards and frameworks, and incorporating a risk-based approach, the HITRUST CSF helps organizations address these challenges through a comprehensive and flexible framework of prescriptive and scalable security controls. "This is a welcome recognition of our ongoing commitment to upholding the highest security and compliance standards," said Phreesia CEO Chaim Indig. "In this challenging time for data security and protection, as Phreesia continues to grow our network and our platform, we take our duty to meet compliance and privacy requirements very seriously. Our clients can be assured that we are a responsible steward of their data, and a trusted partner in their efforts to provide the best care to their patients."

ShowHide Related Items >><<
PHR Phreesia
$69.61 /

+2.485 (+3.70%)

PHR Phreesia
$69.61 /

+2.485 (+3.70%)

09/03/21 SVB Leerink
SVB Leerink says buy the dip in Phreesia
09/03/21 Raymond James
Phreesia price target raised to $75 from $65 at Raymond James
09/03/21 Piper Sandler
Phreesia earnings selloff a buying opportunity, says Piper Sandler
09/03/21 Baird
Phreesia price target raised to $67 from $62 at Baird
PHR Phreesia
$69.61 /

+2.485 (+3.70%)

  • 08
    Apr
  • 21
    Oct
PHR Phreesia
$69.61 /

+2.485 (+3.70%)

Recommendations
SVB Leerink says buy the dip in Phreesia » 09:16
09/03/21
09/03
09:16
09/03/21
09:16
PHR

Phreesia

$62.74 /

-6.73 (-9.69%)

SVB Leerink analyst…

SVB Leerink analyst Stephanie Davis keeps her Outperform rating and $75 price target on Phreesia after its Q2 results and says investors should buy the dip in the stock price. While the company beat on revenue and key metrics, its EBITDA was a miss due to a ramp in hiring, the analyst tells investors in a research note. Davis contends however that "growth does not come cheap", adding that it is necessary for Phreesia to invest in growth given its increasingly competitive market place. The analyst also sees the management's FY22 guidance as likely conservative.

ShowHide Related Items >><<
PHR Phreesia
$62.74 /

-6.73 (-9.69%)

PHR Phreesia
$62.74 /

-6.73 (-9.69%)

09/03/21 Raymond James
Phreesia price target raised to $75 from $65 at Raymond James
09/03/21 Piper Sandler
Phreesia earnings selloff a buying opportunity, says Piper Sandler
09/03/21 Baird
Phreesia price target raised to $67 from $62 at Baird
09/02/21 RBC Capital
Phreesia price target raised to $60 from $51 at RBC Capital
PHR Phreesia
$62.74 /

-6.73 (-9.69%)

  • 08
    Apr
  • 21
    Oct
PHR Phreesia
$62.74 /

-6.73 (-9.69%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.